SCHEMBL6984766

SCHEMBL6984766

CCOC(=O)CCc1ccc(NC(C)=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.64
CYP4A11 Q02928 2/20 0.64
PPID Q08752 1/20 0.60
CYP4Z1 Q86W10 1/20 0.55
TDP1 Q9NUW8 3/20 0.53
LMNA P02545 3/20 0.53
MEN1 O00255 1/20 0.53
CYP1A2 P05177 1/20 0.53
KMT2A Q03164 1/20 0.53
MITF O75030 1/20 0.51
MAPT P10636 3/20 0.49
NAMPT P43490 1/20 0.48
CYP2C19 P33261 1/20 0.48
AOC3 Q16853 1/20 0.48
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27509756 0.86 CYP4F2 (0.62) CYP4F2CYP4A11PPIDCYP4Z1TDP1
SCHEMBL393227 0.85 EPHX2 (0.56) TDP1LMNAMEN1CYP1A2KMT2A
SCHEMBL68902 0.85 CYP4F2 (0.85) CYP4F2CYP4A11CYP4Z1TDP1LMNA
SCHEMBL20642216 0.84 CYP4F2 (0.68) CYP4F2CYP4A11CYP4Z1TDP1MITF
SCHEMBL10685516 0.84 PPID (0.63) PPIDCYP4Z1TDP1LMNAMEN1
SCHEMBL13159630 0.83 CYP4F2 (0.66) CYP4F2CYP4A11CYP4Z1TDP1MITF
SCHEMBL13879886 0.83 CYP4F2 (0.66) CYP4F2CYP4A11CYP4Z1TDP1MITF
SCHEMBL2083708 0.83 CYP4F2 (0.66) CYP4F2CYP4A11CYP4Z1TDP1MITF
SCHEMBL11169633 0.82 PPID (0.55) CYP4F2CYP4A11PPIDTDP1LMNA
SCHEMBL7972075 0.81 CYP4F2 (0.56) CYP4F2CYP4A11PPIDCYP4Z1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1437587-A Benzoxazepinones and their use as squalene synthetase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-08-20 CN disclosed
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed
US-5643925-A COGNITION ACTIVATORS AND NERVE GROWTH FACTORS SANKYO COMPANY, LIMITED (JP) 1997-07-01 US disclosed
US-5614521-A NERVE GROWTH FACTOR SANKYO COMPANY, LIMITED (JP) 1997-03-25 US disclosed
EP-0501656-B1 New benzene derivatives having (NGF) production-promoting activity SANKYO CO (JP) 1997-01-22 EP disclosed
EP-0501656-A2 New benzene derivatives having (NGF) production-promoting activity Sankyo Company Limited (JP) 1992-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 CYP4F2 760/4885CYP4A11 71/4885PPID 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.